Evidence map›Paper›PMID 30608923›Full record

ArticlePloS one2019

Transcriptomic characterization of signaling pathways associated with osteoblastic differentiation of MC-3T3E1 cells.

Louis M Luttrell, Moahad S Dar, Diane Gesty-Palmer, Hesham M El-Shewy, Katherine M Robinson, Courtney J Haycraft, Jeremy L Barth

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TranslatingFrontiers in bioengineering and biotechnology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Epigenetic Regulation ofInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Transcriptomics: a Solution for Renal Osteodystrophy?Current osteoporosis reports · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Louis M LuttrellDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.ORCID 0000-0003-2805-6949
Moahad S DarDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Diane Gesty-PalmerDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Hesham M El-ShewyDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Katherine M RobinsonDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Courtney J HaycraftDepartment of Biology, Mississippi College, Clinton, Mississippi, United States of America.
Jeremy L BarthDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, United States of America.ORCID 0000-0001-6113-8140
Medical University of South Carolina · USDuke Medical Center · USMississippi College · US

Funding

South Carolina IDeA Networks of Biomedical Research (SC INBRE V)P20GM103499 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI EDIE C GOLDSMITH · 2012 to 2026
$61.0M
SC COBRE for Developmentally Based Cardiovascular DiseasesP30GM103342 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 2012 to 2016
$5.5M
Pharmacodynamics of Biased G protein-Coupled Receptor AgonismR01GM095497 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LUTTRELL, LOUIS M · 2013 to 2016
$1.1M
Pharmacodynamics of Biased G Protein-Coupled Receptor AgonismR35GM126955 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LUTTRELL, LOUIS M · 2018 to 2020
$1.1M
Parathyroid Hormone and Osteoblast MitogenesisR01DK064353 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LUTTRELL, LOUIS M · 2002 to 2005
$937k
Functionally-selective parathyroid hormone analogs as therapeutics in metabolic bone diseaseI01BX003188 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI LUTTRELL, LOUIS M · 2017 to 2020
–
BLRD VA I01 BX003188NIDDK NIH HHS R01 DK064353NIGMS NIH HHS P20 GM103499NIGMS NIH HHS P30 GM103342NIGMS NIH HHS R01 GM095497NIGMS NIH HHS R35 GM126955
6 · The paper itself

Abstract

Bone remodeling involves the coordinated actions of osteoclasts, which resorb the calcified bony matrix, and osteoblasts, which refill erosion pits created by osteoclasts to restore skeletal integrity and adapt to changes in mechanical load. Osteoblasts are derived from pluripotent mesenchymal stem cell precursors, which undergo differentiation under the influence of a host of local and environmental cues. To characterize the autocrine/paracrine signaling networks associated with osteoblast maturation and function, we performed gene network analysis using complementary "agnostic" DNA microarray and "targeted" NanoString nCounter datasets derived from murine MC3T3-E1 cells induced to undergo synchronized osteoblastic differentiation in vitro. Pairwise datasets representing changes in gene expression associated with growth arrest (day 2 to 5 in culture), differentiation (day 5 to 10 in culture), and osteoblast maturation (day 10 to 28 in culture) were analyzed using Ingenuity Systems Pathways Analysis to generate predictions about signaling pathway activity based on the temporal sequence of changes in target gene expression. Our data indicate that some pathways involved in osteoblast differentiation, e.g. Wnt/β-catenin signaling, are most active early in the process, while others, e.g. TGFβ/BMP, cytokine/JAK-STAT and TNFα/RANKL signaling, increase in activity as differentiation progresses. Collectively, these pathways contribute to the sequential expression of genes involved in the synthesis and mineralization of extracellular matrix. These results provide insight into the temporal coordination and complex interplay between signaling networks controlling gene expression during osteoblast differentiation. A more complete understanding of these processes may aid the discovery of novel methods to promote osteoblast development for the treatment of conditions characterized by low bone mineral density.

Indexed as

3T3 CellsAnimalsAutocrine CommunicationBone DensityBone RemodelingCell DifferentiationDatasets as TopicExtracellular MatrixGene Expression ProfilingGene Regulatory NetworksMiceOligonucleotide Array Sequence AnalysisOsteoblastsOsteogenesisParacrine CommunicationSignal Transduction

Identifiers

PMID30608923
PMCPMC6319725
OpenAlexW2952791358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.